The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management
Open Access
- 2 April 2015
- Vol. 28 (2) , 221-228
Abstract
Monoinfection with either hepatitis B (HBV) or C virus (HCV) represents one of the major causes of chronic liver disease globally. However, in endemic areas a substantial number of patients are infected with both viruses mainly as a result of the common routes of transmission. Numerous studies have demonstrated that dually infected patients carry a greater risk of advanced liver disease, cirrhosis and hepatocellular carcinoma compared with monoinfected patients. The choice of treatment is based on the virological profile of each patient taking into account the dominant virus pattern. In predominant HCV, standard combination treatment with pegylated interferon and ribavirin has proven equally effective in HBV/HCV-coinfected patients as well as in HCV-monoinfected patients. Strikingly, approximately 60% of patients with inactive HBV infection before HCV treatment may present HBV reactivation while others experience hepatitis B surface antigen seroconversion after clearing HCV, demonstrating the complexity of the interaction between the two viruses during the follow up. The therapeutic strategies for the predominant HBV dually infected patients are more vague, although high genetic barrier nucleos(t)ide analogues play an indisputable role. Finally, the recently approved combination treatments for chronic hepatitis C containing direct-acting antivirals may definitely change the treatment protocols in the future although there is no experience with these drugs in dually infected patients until today.Keywords
This publication has 91 references indexed in Scilit:
- Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B PatientsPLOS ONE, 2013
- Hepatitis C virus (HCV) infection in Africa: a reviewPan African Medical Journal, 2013
- Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In VivoPLOS ONE, 2012
- Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virusThe Korean Journal of Hepatology, 2011
- HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCV #Hepatology, 2009
- Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infectionJournal of Hepatology, 2004
- Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patientsJournal of Hepatology, 1994
- Coinfection of hepatitis C virus in patients with chronic hepatitis B infectionJournal of Hepatology, 1994
- Hepatitis C virus infection in patients with acute hepatitis BInfection, 1992
- Simultaneous acute infections with hepatitis non-A, non-B, and B virusesDigestive Diseases and Sciences, 1982